V
Vistin Pharma ASA
OSE:VISTN
Vistin Pharma ASA
OSE:VISTN
Price:
23.2
NOK
2.65%
Market Closed
Market Cap:
kr1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
NO |
|
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
US |
|
S
|
Siav SpA
MIL:SIAV
|
IT |
Balance Sheet
Balance Sheet Decomposition
Vistin Pharma ASA
Vistin Pharma ASA
Balance Sheet Decomposition is not available for
Vistin Pharma ASA
Vistin Pharma ASA
Balance Sheet
Vistin Pharma ASA
Vistin Pharma ASA
Currency: NOK
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
62
|
89
|
69
|
321
|
320
|
77
|
36
|
1
|
26
|
|
| Cash |
0
|
0
|
69
|
87
|
135
|
0
|
36
|
0
|
0
|
|
| Cash Equivalents |
62
|
89
|
0
|
234
|
185
|
77
|
0
|
1
|
26
|
|
| Total Receivables |
0
|
57
|
36
|
32
|
49
|
33
|
43
|
71
|
60
|
|
| Accounts Receivables |
0
|
45
|
30
|
27
|
38
|
30
|
40
|
66
|
47
|
|
| Other Receivables |
0
|
12
|
6
|
4
|
11
|
2
|
3
|
5
|
13
|
|
| Inventory |
0
|
79
|
23
|
29
|
24
|
32
|
43
|
83
|
80
|
|
| Other Current Assets |
0
|
0
|
32
|
30
|
2
|
0
|
16
|
3
|
3
|
|
| Total Current Assets |
0
|
226
|
160
|
412
|
395
|
142
|
138
|
159
|
169
|
|
| PP&E Net |
0
|
54
|
72
|
89
|
102
|
145
|
167
|
219
|
220
|
|
| PP&E Gross |
0
|
0
|
72
|
89
|
102
|
0
|
167
|
219
|
220
|
|
| Accumulated Depreciation |
0
|
0
|
7
|
12
|
21
|
0
|
41
|
53
|
71
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
8
|
35
|
28
|
29
|
15
|
|
| Total Assets |
0
N/A
|
280
N/A
|
232
-17%
|
500
+116%
|
504
+1%
|
322
-36%
|
333
+3%
|
407
+22%
|
403
-1%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
37
|
49
|
29
|
24
|
18
|
21
|
26
|
19
|
|
| Accrued Liabilities |
0
|
0
|
36
|
18
|
0
|
0
|
20
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
51
|
|
| Other Current Liabilities |
0
|
43
|
12
|
87
|
48
|
14
|
0
|
46
|
0
|
|
| Total Current Liabilities |
0
|
81
|
97
|
134
|
73
|
32
|
41
|
118
|
69
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
12
|
15
|
17
|
16
|
17
|
16
|
16
|
11
|
|
| Total Liabilities |
0
N/A
|
93
N/A
|
112
+20%
|
151
+36%
|
91
-40%
|
50
-45%
|
57
+16%
|
134
+133%
|
81
-40%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
17
|
17
|
44
|
44
|
44
|
44
|
44
|
44
|
|
| Retained Earnings |
0
|
32
|
102
|
28
|
96
|
1
|
25
|
22
|
72
|
|
| Additional Paid In Capital |
0
|
138
|
1
|
276
|
273
|
229
|
207
|
207
|
207
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
187
N/A
|
120
-36%
|
349
+190%
|
413
+19%
|
272
-34%
|
276
+1%
|
273
-1%
|
323
+18%
|
|
| Total Liabilities & Equity |
0
N/A
|
280
N/A
|
232
-17%
|
500
+116%
|
504
+1%
|
322
-36%
|
333
+3%
|
407
+22%
|
403
-1%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
0
|
17
|
17
|
44
|
44
|
44
|
44
|
44
|
44
|
|
Switch to:
Switch to:
See Also
Discover More
